Crossref

1. Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes

- Sarunporn Kamolvisit

- Supphamat Chirnaksorn

- Hataikarn Nimitphong

- Somnuek Sungkanuparph

2. Relationship Between Cardiovascular Disease Risk Factors and Quality of Life in Patients with Metabolic-Associated Fatty Liver Disease

- Raika Jamali

- Soroush Veisi

- Arsia Jamali

- Mehdi Yaseri

3. Comparative efficacy of diabetes medications on liver enzymes and fat fraction in patients with nonalcoholic fatty liver disease: A network meta-analysis,,

- Cai-yan Zou

- Yan Sun

- Jun Liang

4. Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials

- A. Mantovani

- C.D. Byrne

- E. Scorletti

- C.S. Mantzoros

- G. Targher

5. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

- Giulio Marchesini

- Elisabetta Bugianesi

- Patrizia Burra

- Fabio Marra

- Luca Miele

- Anna Alisi

- Piero Vajro

- Mario Masarone

- Salvatore Petta

- Marcello Persico

- Gianluca Svegliati-Baroni

- Luca Valenti

- Massimo Federici

- Francesco Purrello

- Ferdinando Carlo Sasso

- Giovanni Targher

- Luca Busetto

- Maria Letizia Petroni

- Ferruccio Santini

- Calogero Cammà

- Agostino Colli

6. Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines

- Raika Jamali

- Abbas Arj

- Mohsen Razavizade

- Mohammad Hossein Aarabi

7. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD)

- Rosa Lombardi

- Simona Onali

- Douglas Thorburn

- Brian R Davidson

- Kurinchi Selvan Gurusamy

- Emmanuel Tsochatzis

8. Diabetes drugs for nonalcoholic fatty liver disease: a systematic review

- Ian Blazina

- Shelley Selph

9. Mechanism of action and effect of immune-modulating agents in the treatment of psoriasis

- Rehab M. El-Gharabawy

- Amira S. Ahmed

- Amal H. Al-Najjar

10. Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease

- Raika Jamali

- Mohsen Razavizade

- Abbas Arj

- Mohammad Hossein Aarabi

11. Cardiovascular protective effects of PPARγ agonists in hypothyroid rats: protection against oxidative stress

- Yousef Baghcheghi

- Farimah Beheshti

- Mahmoud Hosseini

- Arezoo Gowhari-Shabgah

- Mohammad Ali-Hassanzadeh

- Mahdiyeh Hedayati-Moghadam

12. The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients

- Nasser Aghamohammadzadeh

- Mitra Niafar

- Elham Dalir Abdolahinia

- Farzad Najafipour

- Saeed Mohamadzadeh Gharebaghi

- Khadijeh Adabi

- Elaheh Dalir Abdolahinia

- Hamidreza Ahadi

13. The Effects of Helicobacter Pylori Eradication on Liver Function and Metabolic Profile in Non-diabetic Non-alcoholic Steatohepatitis: A 5-year Randomized Clinical Trial

- Arsia Jamali

- Shahrokh Karbalai

- Ghazale Tefagh

- Raika Jamali

- Ayat Ahmadi

14. Research Progress of the Prevention and Treatment of Metabolic Associated Fatty Liver Disease as a Complication Disease of Endocrine Therapy for Breast Cancer

- 胜鹏 覃

15. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

- Giulio Marchesini

- Elisabetta Bugianesi

- Patrizia Burra

- Fabio Marra

- Luca Miele

- Anna Alisi

- Piero Vajro

- Mario Masarone

- Salvatore Petta

- Marcello Persico

- Gianluca Svegliati-Baroni

- Luca Valenti

- Massimo Federici

- Francesco Purrello

- Ferdinando Carlo Sasso

- Giovanni Targher

- Luca Busetto

- Maria Letizia Petroni

- Ferruccio Santini

- Calogero Cammà

- Agostino Colli

16. Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases?

- Misaq Heydari

- María Eugenia Cornide-Petronio

- Mónica B. Jiménez-Castro

- Carmen Peralta

17. Protein analysis of rat hepatocytes under conditions glutamate-induced obesity and its correction

- D. Voieikova

- L. Stepanova

- O. Savchuk

- L. Ostapchenko

- M. Kondro

18. The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials

- Rachelle Haber

- Fatima Zarzour

- Malak Ghezzawi

- Natalie Saadeh

- Dania S. Bacha

- Lama Al Jebbawi

- Marlene Chakhtoura

- Christos S. Mantzoros

19. Levocetirizine ameliorates high fructose diet-induced insulin resistance, vascular dysfunction and hepatic steatosis in rats

- Noha M. Shawky

- George S.G. Shehatou

- Mona Abdel Rahim

- Ghada M. Suddek

- Nariman M. Gameil

20. Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis

- Chen Ding

- Yaxin Tang

- Wenqiang Zhu

- Piaopiao Huang

- Pingan Lian

- Juanli Ran

- Xiansheng Huang

21. How Does Addition of Regular Aerobic Exercises, Influence the Efficacy of Calorie-Restricted Diet in Patients with Non-Alcoholic Steatohepatatis (NASH)?

- Hossein Nikroo

- Mohsen Nematy

- Seyyed Reza Attarzadeh Hosseini

- Hamid Reza Sima

- Farkhonde Razmpour

22. Improvement of Insulin Sensitivity Increases Pregnancy Rate in Infertile PCOS Women: A Systemic Review

- Yuqi Liu

- Juan Li

- Zhe Yan

- Dan Liu

- Jinfang Ma

- Nanwei Tong

23. Optimized strategy among diet, exercise, and pharmacological interventions for nonalcoholic fatty liver disease: A network meta‐analysis of randomized controlled trials

- Hao Wang

- Qianqian Ma

- Youpeng Chen

- Ling Luo

- Junzhao Ye

- Bihui Zhong

24. The effects of pioglitazone and rosiglitazone on liver function in hypothyroid rats

- Yousef Baghcheghi

- Farimah Beheshti

- Fatemeh Seyedi

- Mahdiyeh Hedayati-Moghadam

- Hedyeh Askarpour

- Aliasghar Kheirkhah

- Ahmad Golkar

- Mohammad Dalfardi

- Mahmoud Hosseini

25. Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis

- Yi-Zhou Huang

- Gang-Yi Yang

- Cong Wang

- Xing-Yu Chen

- Li-Li Zhang

26. Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition

- Minjie Lin

- Shuiping Zhao

- Li Shen

- Danyan Xu

27. The Effect of Berberis Vulgaris Extract on Transaminase Activities in Non-Alcoholic Fatty Liver Disease

- Raziye Iloon Kashkooli

- Seyed Saeed Najafi

- Farkhondeh Sharif

- Azadeh Hamedi

- Mohammad Kazem Hoseini Asl

- Majid Najafi Kalyani

- Mehdi Birjandi

28. Dietary Determinants of Non-Alcoholic Fatty Liver Disease in Lean and Non-Lean Adult Patients: A Population-Based Study in Shiraz, Southern Iran

- Behnam Honarvar

- Kamran Bagheri Lankarani

- Parisa Keshani

- Tayebe Rafiee

29. The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review

- Maria Zachou

- Pagona Flevari

- Narjes Nasiri-Ansari

- Constantinos Varytimiadis

- Evangelos Kalaitzakis

- Eva Kassi

- Theodoros Androutsakos

30. Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes： A Network Meta-Analysis

- Jingxuan Lian

- Jianfang Fu

31. Amelioration of High Fructose Diet-Induced Insulin Resistance, Hyperuricemia, and Liver Oxidative Stress by Combined Use of Selective Agonists of PPAR-α and PPAR-γ in Rats

- Mahmoud M. Farag

- Ehab H. Ashour

- Wessam F. El-Hadidy

32. Which Metabolic Index is Appropriate for Predicting Non-alcoholic Steatohepatitis?

- Raika Jamali

- Mehdi Ebrahimi

- Ali Faryabi

- Haleh Ashraf

33. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

34. Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver

- Yun-Xia Zhu

- Ming-Liang Zhang

- Yuan Zhong

- Chen Wang

- Wei-Ping Jia

35. Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD)

- Zahra Dehnavi

- Farkhonde Razmpour

- Mahmoud Belghaisi Naseri

- Mohsen Nematy

- Seyed Ali Alamdaran

- Hassan Ali Vatanparast

- Mohsen Azimi Nezhad

- Bita Abbasi

- Azita Ganji

36. Evaluation of PEN2-ATP6AP1 axis as an antiparasitic target for metformin based on phylogeny analysis and molecular docking

- Congshan Liu

- Shangrui Zhang

- Jian Xue

- Haobing Zhang

- Jianhai Yin

37. Effect of canagliflozin on liver function tests in patients with type 2 diabetes

- L.A. Leiter

- T. Forst

- D. Polidori

- D.A. Balis

- J. Xie

- S. Sha

38. Comparison of the effects of sulforaphane and pioglitazone on insulin resistance and associated dyslipidemia, hepatosteatosis, and endothelial dysfunction in fructose-fed rats

- Noha M. Shawky

- George S.G. Shehatou

- Ghada M. Suddek

- Nariman M. Gameil

39. Pharmacological treatment and therapeutic perspectives of metabolic syndrome

- Soo Lim

- Robert H. Eckel

40. Pluchea indica Leaf Extract Alleviates Dyslipidemia and Hepatic Steatosis by Modifying the Expression of Lipid Metabolism-Related Genes in Rats Fed a High Fat-High Fructose Diet

- Patcharin Singdam

- Jarinyaporn Naowaboot

- Laddawan Senggunprai

- Kampeebhorn Boonloh

- Patchareewan Pannangpetch

41. Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic

- Kareem Hassan

42. Antidiabetic drugs and non-alcoholic fatty liver disease: A systematic review, meta-analysis and evidence map

- Jai Kumar

- Roha Saeed Memon

- Izza Shahid

- Tehlil Rizwan

- Maryam Zaman

- Ritesh G. Menezes

- Sarwan Kumar

- Tariq Jamal Siddiqi

- Muhammad Shariq Usman